Syncom Formulations (India) Ltd Share Price (SYNCOMF)
Check the latest share price of Syncom Formulations (India) Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 20 Jun 2025
NSE
Syncom Formulations (India) Ltd Stock Performance
Get live Syncom Formulations (India) Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹18.4Day's Price Range₹19.652 Week's Low
52 Week's High
₹12.3152-Week Price Range₹27.9
| Returns % | |
| 1 Month Return | -4.25 % |
| 3 Month Return | + 13.04 % |
| 1 Year Return | + 51.22 % |
| 3 Year Return | + 150.46 % |
| 5 Year Return | + 930.11 % |
| Market Stats | |
| Previous Close | ₹18.68 |
| Open | ₹18.40 |
| Volume | 15.40L |
| Upper Circuit | ₹19.61 |
| Lower Circuit | ₹17.74 |
Syncom Formulations (India) Ltd Fundamentals & Key Indicators
Check Syncom Formulations (India) Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹1,801.04 Cr
Return on Equity (ROE)
8.71
PE Ratio (TTM)
33.61
Return on capital employed (ROCE)
10.32
Industry PE ratio
55.86
Beta (LTM)
1.4
P/B Ratio
3.67
Dividend Yield
0PEG Ratio
146.15
Quarterly Earnings Growth YOY
139.05
EPS (TTM)
0.27
Sector
Pharmaceuticals
Book Value
3.07
Technical Analysis
Bearish
View Technical Analysis
How to invest in Syncom Formulations (India) Ltd?
Investing in Syncom Formulations (India) Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Syncom Formulations (India) Ltd or SYNCOMF on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Syncom Formulations (India) Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Syncom Formulations (India) Ltd with just a few clicks!
Syncom Formulations (India) Ltd Stock's Interest Amongst Investors
Syncom Formulations (India) Ltd Valuation
Track how Syncom Formulations (India) Ltd P/E has moved over time to understand its valuation trends.
Syncom Formulations (India) Ltd in the last 5 years
Lowest (3.98x)
March 12, 2020
Today (33.61x)
June 20, 2025
Industry (55.86x)
June 20, 2025
Highest (81.74x)
January 18, 2022
Today’s Price to Earnings Ratio: 33.61x
Syncom Formulations (India) Ltd Financial Results
Get the annual and quarterly financial summary of Syncom Formulations (India) Ltd, including revenue, profit, loss and more.
Indices Featuring Syncom Formulations (India) Ltd Stock
Check stock indices that include Syncom Formulations (India) Ltd.
Syncom Formulations (India) Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Syncom Formulations (India) Ltd.
Syncom Formulations (India) Ltd Earnings Results
Syncom Formulations (India) Ltd’s net profit jumped 139.05% since last year same period to ₹17.69Cr in the Q4 2024-2025. On a quarterly growth basis, Syncom Formulations (India) Ltd has generated 36.08% jump in its net profits since last 3-months.
Read More about Earnings ResultsSyncom Formulations (India) Ltd Dividends August,2022
In the quarter ending June 2022, Syncom Formulations (India) Ltd has declared dividend of ₹0.03 - translating a dividend yield of 0.16%.
Read More about Dividends
Syncom Formulations (India) Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Syncom Formulations (India) Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 50.57% | 0.00 | |
| Foreign Institutions | 0.11% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 49.32% | 0.00 | |
| Others | 0% | 0.00 |
Syncom Formulations (India) Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Syncom Formulations (India) Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,801.04 | 186.02% | 0.61 | 25 | 263 | |
| NA | 105.45 | 73.96% | 0.56 | 2 | 281 | |
| NA | 77.97 | 45.54% | 0.50 | NA | 6 | |
| BUY | 22,153.86 | 49.69% | 0.75 | 397 | 2,056 | |
| BUY | 15,548.95 | 92.89% | 0.50 | 461 | 1,694 |
Syncom Formulations (India) Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Syncom Formulations (India) Ltd.
Syncom Formulations Reports Exceptional Q4 and FY 2025 Growth - 06 Jun, 2025
Syncom Formulations (India) Ltd reported remarkable financial results for Q4 and FY 2025, with PAT surging 139% to ₹1,769 lakhs and revenue increasing 76% to ₹46,501 lakhs. Strong growth in both export and domestic markets contributed to this performance.
Insights on Syncom Formulations (India) Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, SYNCOMF has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 49.30% to 49.32% in Mar 2025 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 8 quarters, 4.4 Cr → 17.69 Cr (in ₹), with an average increase of 17.2% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, SYNCOMF has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 8 quarters, 61.71 Cr → 155.83 Cr (in ₹), with an average increase of 12.3% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 50.57% of holdings in Mar 2025 quarter
NEGATIVE IMPACTPrice Dip
In the last 7 days, SYNCOMF stock has moved down by -10.0%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 0.13% to 0.11% in Mar 2025 quarter
About Syncom Formulations (India) Ltd
Revenue: ₹148.88Cr as on March 2025 (Q4 FY25)
Net Profit: ₹17.69Cr as on March 2025 (Q4 FY25)
Listing date: 18 Nov, 2022
Chairperson Name: Kedarmal Bankda
| Organisation | Syncom Formulations (India) Ltd |
| Headquarters | Indore |
| Industry | Pharmaceuticals |
| CEO | Kedarmal Bankda |
| E-voting on shares | Click here to vote |
Mutual Funds that own Syncom Formulations (India) Ltd
Check out the Mutual Funds with significant holdings in Syncom Formulations (India) Ltd.
| Funds | Holdings | Prev. 5M |
|---|---|---|
| Bandhan BSE Healthcare Index Fund Direct Growth | 0.08% |
FAQs
What is Syncom Formulations (India) Ltd share price today?
Syncom Formulations (India) Ltd share price today stands at ₹19.16, Open: ₹18.4, Previous Close: ₹18.68, High: ₹19.6, Low: ₹18.4, 52 Week High: ₹27.9, 52 Week Low: ₹12.31.
What is today's traded volume of Syncom Formulations (India) Ltd?
Today's traded volume of Syncom Formulations (India) Ltd is 15.40L. Which means that 15.40L shares of Syncom Formulations (India) Ltd were bought and sold on the stock market during today's trading session.
What is Syncom Formulations (India) Ltd's market cap today?
Today's market capitalisation of Syncom Formulations (India) Ltd is ₹1,801.04 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Syncom Formulations (India) Ltd?
Syncom Formulations (India) Ltd’s 52 week high is ₹27.9 and 52 week low is ₹12.31. The current share price of Syncom Formulations (India) Ltd is ₹19.16, which is -31.33% down from its 52 week high and 55.65% up from its 52 week low.